BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33741274)

  • 21. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of vagina equivalent dose in 2Gy fraction (EQD
    Ruanla J; Muangwong P; Kittidachanan K; Tippanya D; Thongsuk W; Kongsa A; Galalae RM; Tharavichitkul E
    Brachytherapy; 2022; 21(5):658-667. PubMed ID: 35715305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definitive radiation for advanced cervix cancer is not associated with vaginal shortening-a prospective vaginal length and dose correlation.
    Owrangi A; Medrano A; Gao Y; Kazemifar S; Hrycushko B; Medin P; Nwachukwu C; Jia X; Albuquerque K
    Brachytherapy; 2024; 23(2):136-140. PubMed ID: 38242726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimension anatomy-based planning optimization for high dose rate vaginal vault brachytherapy.
    Bahadur YA; Hassouna AH; Constantinescu CT; Naga AF; Ghasal NM; Elsayed ME
    Saudi Med J; 2012 Jun; 33(6):640-7. PubMed ID: 22729119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary application in cervical cancer.
    Atasever Akkas E; Altundag MB
    J BUON; 2021; 26(3):698-706. PubMed ID: 34268923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of morbidity after external radiotherapy and intracavitary brachytherapy in 771 patients with carcinoma of the uterine cervix or endometrium.
    Yalman D; Arican A; Ozsaran Z; Celik OK; Yürüt V; Esassolak M; Haydaroglu A
    Eur J Gynaecol Oncol; 2002; 23(1):58-62. PubMed ID: 11876395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing brachytherapy for locally advanced cervical cancer.
    Niël CG; Koper PC; Visser AG; Sipkema D; Levendag PC
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):873-7. PubMed ID: 8040037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer.
    Eng TY; Patel AJ; Ha CS
    Brachytherapy; 2016; 15(3):312-318. PubMed ID: 27032995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-related factors determining geometry of intracavitary applicators and pelvic dose distribution during cervical cancer brachytherapy.
    Senkus-Konefka E; Kobierska A; Jassem J; Badzio A
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):531-6. PubMed ID: 9112449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definition of vaginal doses in intrauterine high-dose-rate brachytherapy.
    Nevelsky A; Bar-Deroma R; Cokal GY; Rosenblatt E; Kuten A
    Brachytherapy; 2004; 3(2):101-5. PubMed ID: 15374542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
    Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer.
    Terahara A; Nakano T; Ishikawa A; Morita S; Tsuji H
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):549-54. PubMed ID: 8655379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
    Limkin EJ; Dumas I; Rivin Del Campo E; Chargari C; Maroun P; Annède P; Petit C; Seisen T; Doyeux K; Tailleur A; Martinetti F; Lefkopoulos D; Haie-Meder C; Mazeron R
    Brachytherapy; 2016; 15(2):169-76. PubMed ID: 26778755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.